Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Molecular Diagnostics Cancer Market Size Analysis from 2022 to 2027
1.5.1 Global Molecular Diagnostics Cancer Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Molecular Diagnostics Cancer Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Molecular Diagnostics Cancer Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Molecular Diagnostics Cancer Industry Impact
Chapter 2 Global Molecular Diagnostics Cancer Competition by Types, Applications, and Top Regions and Countries
2.1 Global Molecular Diagnostics Cancer (Volume and Value) by Type
2.1.1 Global Molecular Diagnostics Cancer Consumption and Market Share by Type (2016-2021)
2.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2016-2021)
2.2 Global Molecular Diagnostics Cancer (Volume and Value) by Application
2.2.1 Global Molecular Diagnostics Cancer Consumption and Market Share by Application (2016-2021)
2.2.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Application (2016-2021)
2.3 Global Molecular Diagnostics Cancer (Volume and Value) by Regions
2.3.1 Global Molecular Diagnostics Cancer Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Molecular Diagnostics Cancer Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Molecular Diagnostics Cancer Consumption by Regions (2016-2021)
4.2 North America Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
4.10 South America Molecular Diagnostics Cancer Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Molecular Diagnostics Cancer Market Analysis
5.1 North America Molecular Diagnostics Cancer Consumption and Value Analysis
5.1.1 North America Molecular Diagnostics Cancer Market Under COVID-19
5.2 North America Molecular Diagnostics Cancer Consumption Volume by Types
5.3 North America Molecular Diagnostics Cancer Consumption Structure by Application
5.4 North America Molecular Diagnostics Cancer Consumption by Top Countries
5.4.1 United States Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
5.4.2 Canada Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
5.4.3 Mexico Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 6 East Asia Molecular Diagnostics Cancer Market Analysis
6.1 East Asia Molecular Diagnostics Cancer Consumption and Value Analysis
6.1.1 East Asia Molecular Diagnostics Cancer Market Under COVID-19
6.2 East Asia Molecular Diagnostics Cancer Consumption Volume by Types
6.3 East Asia Molecular Diagnostics Cancer Consumption Structure by Application
6.4 East Asia Molecular Diagnostics Cancer Consumption by Top Countries
6.4.1 China Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
6.4.2 Japan Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
6.4.3 South Korea Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 7 Europe Molecular Diagnostics Cancer Market Analysis
7.1 Europe Molecular Diagnostics Cancer Consumption and Value Analysis
7.1.1 Europe Molecular Diagnostics Cancer Market Under COVID-19
7.2 Europe Molecular Diagnostics Cancer Consumption Volume by Types
7.3 Europe Molecular Diagnostics Cancer Consumption Structure by Application
7.4 Europe Molecular Diagnostics Cancer Consumption by Top Countries
7.4.1 Germany Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.2 UK Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.3 France Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.4 Italy Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.5 Russia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.6 Spain Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.7 Netherlands Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.8 Switzerland Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
7.4.9 Poland Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 8 South Asia Molecular Diagnostics Cancer Market Analysis
8.1 South Asia Molecular Diagnostics Cancer Consumption and Value Analysis
8.1.1 South Asia Molecular Diagnostics Cancer Market Under COVID-19
8.2 South Asia Molecular Diagnostics Cancer Consumption Volume by Types
8.3 South Asia Molecular Diagnostics Cancer Consumption Structure by Application
8.4 South Asia Molecular Diagnostics Cancer Consumption by Top Countries
8.4.1 India Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
8.4.2 Pakistan Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Molecular Diagnostics Cancer Market Analysis
9.1 Southeast Asia Molecular Diagnostics Cancer Consumption and Value Analysis
9.1.1 Southeast Asia Molecular Diagnostics Cancer Market Under COVID-19
9.2 Southeast Asia Molecular Diagnostics Cancer Consumption Volume by Types
9.3 Southeast Asia Molecular Diagnostics Cancer Consumption Structure by Application
9.4 Southeast Asia Molecular Diagnostics Cancer Consumption by Top Countries
9.4.1 Indonesia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.2 Thailand Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.3 Singapore Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.4 Malaysia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.5 Philippines Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.6 Vietnam Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
9.4.7 Myanmar Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 10 Middle East Molecular Diagnostics Cancer Market Analysis
10.1 Middle East Molecular Diagnostics Cancer Consumption and Value Analysis
10.1.1 Middle East Molecular Diagnostics Cancer Market Under COVID-19
10.2 Middle East Molecular Diagnostics Cancer Consumption Volume by Types
10.3 Middle East Molecular Diagnostics Cancer Consumption Structure by Application
10.4 Middle East Molecular Diagnostics Cancer Consumption by Top Countries
10.4.1 Turkey Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.3 Iran Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.5 Israel Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.6 Iraq Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.7 Qatar Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.8 Kuwait Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
10.4.9 Oman Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 11 Africa Molecular Diagnostics Cancer Market Analysis
11.1 Africa Molecular Diagnostics Cancer Consumption and Value Analysis
11.1.1 Africa Molecular Diagnostics Cancer Market Under COVID-19
11.2 Africa Molecular Diagnostics Cancer Consumption Volume by Types
11.3 Africa Molecular Diagnostics Cancer Consumption Structure by Application
11.4 Africa Molecular Diagnostics Cancer Consumption by Top Countries
11.4.1 Nigeria Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
11.4.2 South Africa Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
11.4.3 Egypt Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
11.4.4 Algeria Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
11.4.5 Morocco Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 12 Oceania Molecular Diagnostics Cancer Market Analysis
12.1 Oceania Molecular Diagnostics Cancer Consumption and Value Analysis
12.2 Oceania Molecular Diagnostics Cancer Consumption Volume by Types
12.3 Oceania Molecular Diagnostics Cancer Consumption Structure by Application
12.4 Oceania Molecular Diagnostics Cancer Consumption by Top Countries
12.4.1 Australia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
12.4.2 New Zealand Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 13 South America Molecular Diagnostics Cancer Market Analysis
13.1 South America Molecular Diagnostics Cancer Consumption and Value Analysis
13.1.1 South America Molecular Diagnostics Cancer Market Under COVID-19
13.2 South America Molecular Diagnostics Cancer Consumption Volume by Types
13.3 South America Molecular Diagnostics Cancer Consumption Structure by Application
13.4 South America Molecular Diagnostics Cancer Consumption Volume by Major Countries
13.4.1 Brazil Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.2 Argentina Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.3 Columbia Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.4 Chile Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.5 Venezuela Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.6 Peru Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
13.4.8 Ecuador Molecular Diagnostics Cancer Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Molecular Diagnostics Cancer Business
14.1 Roche
14.1.1 Roche Company Profile
14.1.2 Roche Molecular Diagnostics Cancer Product Specification
14.1.3 Roche Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Invitae
14.2.1 Invitae Company Profile
14.2.2 Invitae Molecular Diagnostics Cancer Product Specification
14.2.3 Invitae Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Abbott Laboratories
14.3.1 Abbott Laboratories Company Profile
14.3.2 Abbott Laboratories Molecular Diagnostics Cancer Product Specification
14.3.3 Abbott Laboratories Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Danaher
14.4.1 Danaher Company Profile
14.4.2 Danaher Molecular Diagnostics Cancer Product Specification
14.4.3 Danaher Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 MDxHealth
14.5.1 MDxHealth Company Profile
14.5.2 MDxHealth Molecular Diagnostics Cancer Product Specification
14.5.3 MDxHealth Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Siemens
14.6.1 Siemens Company Profile
14.6.2 Siemens Molecular Diagnostics Cancer Product Specification
14.6.3 Siemens Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Thermo Fisher Scientific
14.7.1 Thermo Fisher Scientific Company Profile
14.7.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Specification
14.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 AstraZeneca
14.8.1 AstraZeneca Company Profile
14.8.2 AstraZeneca Molecular Diagnostics Cancer Product Specification
14.8.3 AstraZeneca Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 ICON Plc
14.9.1 ICON Plc Company Profile
14.9.2 ICON Plc Molecular Diagnostics Cancer Product Specification
14.9.3 ICON Plc Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 PlexBio
14.10.1 PlexBio Company Profile
14.10.2 PlexBio Molecular Diagnostics Cancer Product Specification
14.10.3 PlexBio Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Foundation Medicine
14.11.1 Foundation Medicine Company Profile
14.11.2 Foundation Medicine Molecular Diagnostics Cancer Product Specification
14.11.3 Foundation Medicine Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 CytoTrack
14.12.1 CytoTrack Company Profile
14.12.2 CytoTrack Molecular Diagnostics Cancer Product Specification
14.12.3 CytoTrack Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Guardant Health
14.13.1 Guardant Health Company Profile
14.13.2 Guardant Health Molecular Diagnostics Cancer Product Specification
14.13.3 Guardant Health Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Luminex
14.14.1 Luminex Company Profile
14.14.2 Luminex Molecular Diagnostics Cancer Product Specification
14.14.3 Luminex Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 10X Genomics
14.15.1 10X Genomics Company Profile
14.15.2 10X Genomics Molecular Diagnostics Cancer Product Specification
14.15.3 10X Genomics Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Merck
14.16.1 Merck Company Profile
14.16.2 Merck Molecular Diagnostics Cancer Product Specification
14.16.3 Merck Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Biocartis
14.17.1 Biocartis Company Profile
14.17.2 Biocartis Molecular Diagnostics Cancer Product Specification
14.17.3 Biocartis Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 GenomOncology
14.18.1 GenomOncology Company Profile
14.18.2 GenomOncology Molecular Diagnostics Cancer Product Specification
14.18.3 GenomOncology Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Biodesix
14.19.1 Biodesix Company Profile
14.19.2 Biodesix Molecular Diagnostics Cancer Product Specification
14.19.3 Biodesix Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Bio-Techne
14.20.1 Bio-Techne Company Profile
14.20.2 Bio-Techne Molecular Diagnostics Cancer Product Specification
14.20.3 Bio-Techne Molecular Diagnostics Cancer Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Molecular Diagnostics Cancer Market Forecast (2022-2027)
15.1 Global Molecular Diagnostics Cancer Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Molecular Diagnostics Cancer Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Molecular Diagnostics Cancer Value and Growth Rate Forecast (2022-2027)
15.2 Global Molecular Diagnostics Cancer Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Molecular Diagnostics Cancer Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Molecular Diagnostics Cancer Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Molecular Diagnostics Cancer Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Molecular Diagnostics Cancer Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Molecular Diagnostics Cancer Consumption Forecast by Type (2022-2027)
15.3.2 Global Molecular Diagnostics Cancer Revenue Forecast by Type (2022-2027)
15.3.3 Global Molecular Diagnostics Cancer Price Forecast by Type (2022-2027)
15.4 Global Molecular Diagnostics Cancer Consumption Volume Forecast by Application (2022-2027)
15.5 Molecular Diagnostics Cancer Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
